Still searching for a new therapeutic strategy for acute myocardial infarction.
Yoshihiko
Y
Saito
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D002317:Cardiovascular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D023903:Coronary Restenosis / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D042783:Endothelial Cells / Q000187:drug effects / Q000473:pathology; D004921:Erythropoietin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006965:Hyperplasia; D009203:Myocardial Infarction / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D009206:Myocardium / Q000473:pathology; D011994:Recombinant Proteins; D013318:Stroke Volume / Q000187:drug effects; D013997:Time Factors; D016896:Treatment Outcome; D016277:Ventricular Function, Left / Q000187:drug effects; D020257:Ventricular Remodeling / Q000187:drug effects*
D002317:Cardiovascular Agents; D011994:Recombinant Proteins; C103998:epoetin beta; D004921:Erythropoietin